Publications
Export 17 results:
Filters: Keyword is Tumor Suppressor Protein p53 [Clear All Filters]
Genetic modifiers regulating DNA replication and double-strand break repair are associated with differences in mammary tumors in mouse models of Li-Fraumeni syndrome. Oncogene, 40(31), 5026-5037. presented at the 2021 08. doi:10.1038/s41388-021-01892-5
. (2021). Use of p53-Silenced Endothelial Progenitor Cells to Treat Ischemia in Diabetic Peripheral Vascular Disease. J Am Heart Assoc, 6(4). presented at the 2017 Apr 01. doi:10.1161/JAHA.116.005146
. (2017). Map making in the 21st century: charting breast cancer susceptibility pathways in rodent models. J Mammary Gland Biol Neoplasia, 16(1), 57-64. presented at the 2011 Apr.
. (2011). Mitochondrial dysfunction impairs tumor suppressor p53 expression/function. J Biol Chem, 286(23), 20297-312. presented at the 2011 Jun 10.
. (2011). Radiation acts on the microenvironment to affect breast carcinogenesis by distinct mechanisms that decrease cancer latency and affect tumor type. Cancer cell, 19(5), 640-51. presented at the 2011 May 17.
. (2011). Wdr74 is required for blastocyst formation in the mouse. PloS one, 6(7), e22516. presented at the 2011.
. (2011). Estrogens, regulation of p53 and breast cancer risk: a balancing act. Cell Mol Life Sci, 67(7), 1017-23. presented at the 2010 Apr.
. (2010). Pathways contributing to development of spontaneous mammary tumors in BALB/c-Trp53+/- mice. Am J Pathol, 176(3), 1421-32. presented at the 2010 Mar.
. (2010). Role of JNK in a Trp53-dependent mouse model of breast cancer. PLoS One, 5(8), e12469. presented at the 2010.
. (2010). . (2008).
Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology, 149(10), 4809-20. presented at the 2008 Oct.
. (2008). Genetic mapping in mice identifies DMBT1 as a candidate modifier of mammary tumors and breast cancer risk. Am J Pathol, 170(6), 2030-41. presented at the 2007 Jun.
. (2007). Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways. Oncogene, 24(42), 6345-53. presented at the 2005 Sep 22.
. (2005). Sensitivity to DNA damage is a common component of hormone-based strategies for protection of the mammary gland. Mol Cancer Res, 3(8), 435-42. presented at the 2005 Aug.
. (2005). Loss of heterozygosity occurs via mitotic recombination in Trp53+/- mice and associates with mammary tumor susceptibility of the BALB/c strain. Cancer Res, 64(15), 5140-7. presented at the 2004 Aug 1.
. (2004). Epithelial cell cycling predicts p53 responsiveness to gamma-irradiation during post-natal mammary gland development. Development, 129(12), 2997-3008. presented at the 2002 Jun.
. (2002). . (2002).
Veterinary and Animal Sciences